ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	geneID	geneName	Count
hsa05144	Malaria	6/69	51/5868	2.51814567313877e-05	0.00239713837224209	3576/3040/3039/3043/3553/2994	CXCL8/HBA2/HBA1/HBB/IL1B/GYPB	6
hsa05143	African trypanosomiasis	5/69	35/5868	4.79427674448419e-05	0.00239713837224209	3040/3039/3043/3553/355	HBA2/HBA1/HBB/IL1B/FAS	5
hsa04380	Osteoclast differentiation	8/69	128/5868	0.000112706721697735	0.00375689072325783	2353/3726/4792/3727/2354/3725/9021/3553	FOS/JUNB/NFKBIA/JUND/FOSB/JUN/SOCS3/IL1B	8
hsa04620	Toll-like receptor signaling pathway	6/69	102/5868	0.0011768231280332	0.0246118939441492	2353/3576/4792/3725/3553/1326	FOS/CXCL8/NFKBIA/JUN/IL1B/MAP3K8	6
hsa05142	Chagas disease (American trypanosomiasis)	6/69	104/5868	0.00130196160940104	0.0246118939441492	2353/3576/4792/3725/3553/355	FOS/CXCL8/NFKBIA/JUN/IL1B/FAS	6
hsa05140	Leishmaniasis	5/69	72/5868	0.00147671363664895	0.0246118939441492	2353/5743/4792/3725/3553	FOS/PTGS2/NFKBIA/JUN/IL1B	5
hsa04010	MAPK signaling pathway	9/69	268/5868	0.00385808055343044	0.0512090434927909	2353/1843/3727/1844/3725/3553/1326/355/7850	FOS/DUSP1/JUND/DUSP2/JUN/IL1B/MAP3K8/FAS/IL1R2	9
hsa05323	Rheumatoid arthritis	5/69	91/5868	0.0041336826150309	0.0512090434927909	2353/3576/3725/3553/2919	FOS/CXCL8/JUN/IL1B/CXCL1	5
hsa04621	NOD-like receptor signaling pathway	4/69	58/5868	0.00460881391435118	0.0512090434927909	3576/4792/3553/2919	CXCL8/NFKBIA/IL1B/CXCL1	4
hsa05146	Amoebiasis	5/69	106/5868	0.00786900759139707	0.073669810927425	3576/2335/3553/2919/7850	CXCL8/FN1/IL1B/CXCL1/IL1R2	5
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4/69	68/5868	0.00810367920201675	0.073669810927425	3576/4792/3725/2919	CXCL8/NFKBIA/JUN/CXCL1	4
hsa05200	Pathways in cancer	9/69	326/5868	0.0134097893273224	0.111748244394354	2353/5743/3576/2335/4792/7170/3725/3091/355	FOS/PTGS2/CXCL8/FN1/NFKBIA/TPM3/JUN/HIF1A/FAS	9
hsa00360	Phenylalanine metabolism	2/69	17/5868	0.0165383014754368	0.127217703657206	9588/4282	PRDX6/MIF	2
hsa03010	Ribosome	4/69	91/5868	0.021758109593008	0.155415068521485	6173/6204/6139/6129	RPL36A/RPS10/RPL17/RPL7	4
hsa05131	Shigellosis	3/69	61/5868	0.0344882220106371	0.219221313067449	3576/4792/71	CXCL8/NFKBIA/ACTG1	3
hsa04060	Cytokine-cytokine receptor interaction	7/69	265/5868	0.0350754100907918	0.219221313067449	3576/5008/7852/3553/2919/355/7850	CXCL8/OSM/CXCR4/IL1B/CXCL1/FAS/IL1R2	7
hsa04660	T cell receptor signaling pathway	4/69	108/5868	0.0376487564425969	0.221463273191747	2353/4792/3725/1326	FOS/NFKBIA/JUN/MAP3K8	4
hsa04920	Adipocytokine signaling pathway	3/69	68/5868	0.0453365023004146	0.251869457224526	4792/9021/8660	NFKBIA/SOCS3/IRS2	3
hsa05416	Viral myocarditis	3/69	70/5868	0.0487131213189472	0.256384849047091	71/4627/1604	ACTG1/MYH9/CD55	3
hsa04662	B cell receptor signaling pathway	3/69	75/5868	0.0576784872222432	0.288392436111216	2353/4792/3725	FOS/NFKBIA/JUN	3
hsa05020	Prion diseases	2/69	35/5868	0.0632297904337847	0.301094240160879	1958/3553	EGR1/IL1B	2
hsa03015	mRNA surveillance pathway	3/69	83/5868	0.0735209392261781	0.311875489108672	2107/2935/10284	ETF1/GSPT1/SAP18	3
hsa05222	Small cell lung cancer	3/69	85/5868	0.0777570013369188	0.311875489108672	5743/2335/4792	PTGS2/FN1/NFKBIA	3
hsa04210	Apoptosis	3/69	87/5868	0.0820988500503213	0.311875489108672	4792/3553/355	NFKBIA/IL1B/FAS	3
hsa05332	Graft-versus-host disease	2/69	41/5868	0.0833519204526869	0.311875489108672	3553/355	IL1B/FAS	2
hsa04640	Hematopoietic cell lineage	3/69	88/5868	0.0843087216969387	0.311875489108672	3553/1604/7850	IL1B/CD55/IL1R2	3
hsa04960	Aldosterone-regulated sodium reabsorption	2/69	42/5868	0.0868756895226364	0.311875489108672	6446/8660	SGK1/IRS2	2
hsa00860	Porphyrin and chlorophyll metabolism	2/69	43/5868	0.090443891841515	0.311875489108672	2495/212	FTH1/ALAS2	2
hsa04940	Type I diabetes mellitus	2/69	43/5868	0.090443891841515	0.311875489108672	3553/355	IL1B/FAS	2
hsa04930	Type II diabetes mellitus	2/69	48/5868	0.108900043552263	0.36300014517421	9021/8660	SOCS3/IRS2	2
hsa04150	mTOR signaling pathway	2/69	52/5868	0.124319569350841	0.400659108286863	54541/3091	DDIT4/HIF1A	2
hsa00330	Arginine and proline metabolism	2/69	54/5868	0.132218613661333	0.400659108286863	6303/26	SAT1/AOC1	2
hsa05010	Alzheimer's disease	4/69	167/5868	0.132587792956147	0.400659108286863	6622/3553/7388/355	SNCA/IL1B/UQCRH/FAS	4
hsa04623	Cytosolic DNA-sensing pathway	2/69	56/5868	0.140230687900402	0.400659108286863	4792/3553	NFKBIA/IL1B	2
hsa05130	Pathogenic Escherichia coli infection	2/69	56/5868	0.140230687900402	0.400659108286863	71/7277	ACTG1/TUBA4A	2
hsa00590	Arachidonic acid metabolism	2/69	59/5868	0.152440283431215	0.423445231753374	5743/2876	PTGS2/GPX1	2
hsa00900	Terpenoid backbone biosynthesis	1/69	15/5868	0.16275524664198	0.433823624383667	3422	IDI1	1
hsa05210	Colorectal cancer	2/69	62/5868	0.164852977265793	0.433823624383667	2353/3725	FOS/JUN	2
hsa04062	Chemokine signaling pathway	4/69	189/5868	0.181543938896822	0.434171670828508	3576/4792/7852/2919	CXCL8/NFKBIA/CXCR4/CXCL1	4
hsa03040	Spliceosome	3/69	127/5868	0.187285332509987	0.434171670828508	1655/220988/6427	DDX5/HNRNPA3/SRSF2	3
hsa04722	Neurotrophin signaling pathway	3/69	127/5868	0.187285332509987	0.434171670828508	4792/3725/8660	NFKBIA/JUN/IRS2	3
hsa04610	Complement and coagulation cascades	2/69	69/5868	0.194449334708213	0.434171670828508	5329/1604	PLAUR/CD55	2
hsa05012	Parkinson's disease	3/69	130/5868	0.196265034492964	0.434171670828508	6622/7388/7314	SNCA/UQCRH/UBB	3
hsa05100	Bacterial invasion of epithelial cells	2/69	70/5868	0.198735693925544	0.434171670828508	2335/71	FN1/ACTG1	2
hsa05211	Renal cell carcinoma	2/69	70/5868	0.198735693925544	0.434171670828508	3725/3091	JUN/HIF1A	2
hsa04622	RIG-I-like receptor signaling pathway	2/69	71/5868	0.203033924517844	0.434171670828508	3576/4792	CXCL8/NFKBIA	2
hsa04510	Focal adhesion	4/69	200/5868	0.208042110263225	0.434171670828508	2335/7094/3725/71	FN1/TLN1/JUN/ACTG1	4
hsa05160	Hepatitis C	3/69	134/5868	0.208402401997684	0.434171670828508	3576/4792/9021	CXCL8/NFKBIA/SOCS3	3
hsa04260	Cardiac muscle contraction	2/69	77/5868	0.229025940887486	0.467399879362217	7170/7388	TPM3/UQCRH	2
hsa04810	Regulation of actin cytoskeleton	4/69	213/5868	0.240715296804459	0.481430593608918	2335/71/4627/89846	FN1/ACTG1/MYH9/FGD3	4
hsa04320	Dorso-ventral axis formation	1/69	24/5868	0.247566056469799	0.48542364013686	2114	ETS2	1
hsa05410	Hypertrophic cardiomyopathy (HCM)	2/69	83/5868	0.255244645828344	0.49085508813143	7170/71	TPM3/ACTG1	2
hsa05414	Dilated cardiomyopathy	2/69	90/5868	0.285919658790677	0.529025111442289	7170/71	TPM3/ACTG1	2
hsa00340	Histidine metabolism	1/69	29/5868	0.290963811293259	0.529025111442289	26	AOC1	1
hsa05216	Thyroid cancer	1/69	29/5868	0.290963811293259	0.529025111442289	7170	TPM3	1
hsa05310	Asthma	1/69	30/5868	0.299342557143707	0.534540280613762	5553	PRG2	1
hsa00260	Glycine, serine and threonine metabolism	1/69	32/5868	0.315808386593078	0.544497218263927	212	ALAS2	1
hsa00640	Propanoate metabolism	1/69	32/5868	0.315808386593078	0.544497218263927	3939	LDHA	1
hsa03410	Base excision repair	1/69	33/5868	0.323897697992166	0.548979149139264	3146	HMGB1	1
hsa04140	Regulation of autophagy	1/69	34/5868	0.331892738067322	0.553154563445537	11345	GABARAPL2	1
hsa00270	Cysteine and methionine metabolism	1/69	36/5868	0.347604322594777	0.560652133217382	3939	LDHA	1
hsa03022	Basal transcription factors	1/69	36/5868	0.347604322594777	0.560652133217382	6881	TAF10	1
hsa05330	Allograft rejection	1/69	37/5868	0.355322995732801	0.564004755131431	355	FAS	1
hsa00620	Pyruvate metabolism	1/69	40/5868	0.377943059198679	0.584793758796321	3939	LDHA	1
hsa00350	Tyrosine metabolism	1/69	41/5868	0.385307837667329	0.584793758796321	4282	MIF	1
hsa00380	Tryptophan metabolism	1/69	42/5868	0.392586670548907	0.584793758796321	26	AOC1	1
hsa05219	Bladder cancer	1/69	42/5868	0.392586670548907	0.584793758796321	3576	CXCL8	1
hsa04670	Leukocyte transendothelial migration	2/69	116/5868	0.397659755981498	0.584793758796321	71/7852	ACTG1/CXCR4	2
hsa04672	Intestinal immune network for IgA production	1/69	48/5868	0.434509383331047	0.62972374395804	7852	CXCR4	1
hsa00480	Glutathione metabolism	1/69	50/5868	0.447839578585642	0.632416830173477	2876	GPX1	1
hsa05320	Autoimmune thyroid disease	1/69	52/5868	0.460859991926803	0.632416830173477	355	FAS	1
hsa04530	Tight junction	2/69	132/5868	0.462580714523465	0.632416830173477	71/4627	ACTG1/MYH9	2
hsa05014	Amyotrophic lateral sclerosis (ALS)	1/69	53/5868	0.467256254058345	0.632416830173477	2876	GPX1	1
hsa05110	Vibrio cholerae infection	1/69	54/5868	0.473577718971497	0.632416830173477	71	ACTG1	1
hsa04120	Ubiquitin mediated proteolysis	2/69	135/5868	0.474312622630108	0.632416830173477	9021/27338	SOCS3/UBE2S	2
hsa04910	Insulin signaling pathway	2/69	138/5868	0.48589347104006	0.639333514526394	9021/8660	SOCS3/IRS2	2
hsa03013	RNA transport	2/69	151/5868	0.534246848524573	0.684802311615155	10209/10284	EIF1/SAP18	2
hsa00010	Glycolysis / Gluconeogenesis	1/69	65/5868	0.538416877535095	0.684802311615155	3939	LDHA	1
hsa04145	Phagosome	2/69	153/5868	0.541412656948747	0.684802311615155	71/7277	ACTG1/TUBA4A	2
hsa04630	Jak-STAT signaling pathway	2/69	155/5868	0.54850382796299	0.684802311615155	5008/9021	OSM/SOCS3	2
hsa04115	p53 signaling pathway	1/69	68/5868	0.554689872408276	0.684802311615155	355	FAS	1
hsa03018	RNA degradation	1/69	71/5868	0.570397191716478	0.68889202354999	7832	BTG2	1
hsa04520	Adherens junction	1/69	73/5868	0.580564073524513	0.68889202354999	71	ACTG1	1
hsa05220	Chronic myeloid leukemia	1/69	73/5868	0.580564073524513	0.68889202354999	4792	NFKBIA	1
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1/69	74/5868	0.585558220017492	0.68889202354999	71	ACTG1	1
hsa04370	VEGF signaling pathway	1/69	76/5868	0.59537135281083	0.692292270710267	5743	PTGS2	1
hsa04512	ECM-receptor interaction	1/69	85/5868	0.636770774674712	0.723006974306251	2335	FN1	1
hsa05016	Huntington's disease	2/69	183/5868	0.639780648581205	0.723006974306251	2876/7388	GPX1/UQCRH	2
hsa04012	ErbB signaling pathway	1/69	87/5868	0.645387561536352	0.723006974306251	3725	JUN	1
hsa05215	Prostate cancer	1/69	89/5868	0.653802827865044	0.723006974306251	4792	NFKBIA	1
hsa04540	Gap junction	1/69	90/5868	0.657936346618689	0.723006974306251	7277	TUBA4A	1
hsa04144	Endocytosis	2/69	201/5868	0.690573353442334	0.750623210263407	7852/51510	CXCR4/CHMP5	2
hsa04912	GnRH signaling pathway	1/69	101/5868	0.700315373131697	0.753027282937308	3725	JUN	1
hsa04360	Axon guidance	1/69	129/5868	0.786229158213643	0.826925665628877	7852	CXCR4	1
hsa00190	Oxidative phosphorylation	1/69	132/5868	0.793848639003722	0.826925665628877	7388	UQCRH	1
hsa05145	Toxoplasmosis	1/69	132/5868	0.793848639003722	0.826925665628877	4792	NFKBIA	1
hsa04650	Natural killer cell mediated cytotoxicity	1/69	136/5868	0.803593004228655	0.828446396112015	355	FAS	1
hsa04310	Wnt signaling pathway	1/69	150/5868	0.834255880001463	0.851281510205575	3725	JUN	1
hsa00230	Purine metabolism	1/69	162/5868	0.856746282022159	0.86188148221072	5142	PDE4B	1
hsa04141	Protein processing in endoplasmic reticulum	1/69	165/5868	0.86188148221072	0.86188148221072	23645	PPP1R15A	1